Pubblicazioni

Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study

2022 - ANNALS OF TRANSLATIONAL MEDICINE

Zhou, Meirong; Wang, Shouman; Wan, Nengbin; Yuan, Songlin; Hu, Xiongqiang; Zhou, Wei; Qing, Bohua; Liu, Mingwen; Sun, Weihua; Fan, Peizhi; Wang, Jianguo; Cao, Hong; Xu, Haifan; Dai, Bin; Tang, Peizhi; Qian, Liyuan; Zhao, Xi; Xiao, Jun; Zhou, Huaiying; Hu, Jinhui; Ding, Li; Tripodi, Domenico; Zdenkowski, Nicholas; OâKeefe, Thomas J.; Sanchez, Alejandro Martin; Chen, Li; Zhang, Ping; Xu, Feng

Current challenges in HER2-positive breast cancer

2016 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Puglisi, Fabio; Fontanella, Caterina; Amoroso, Vito; Bianchi, Giulia Valeria; Bisagni, Giancarlo; Falci, Cristina; Fontana, Andrea; Generali, Daniele; Gianni, Lorenzo; Grassadonia, Antonio; Moscetti, Luca; Portarena, Ilaria; Rossi, Emanuela; Marchetti, Paolo